[1P-0100] Precision Medicine to Provide Resistance to SARS-CoV-2 Infection by Switching OAS1 Splicing Isoforms

^○Kei IIDA¹, Masahiko Ajiro¹, Yukiko Muramoto^{2, 3}, Toru Takenaga^{2, 3}, Masatsugu Denawa¹, Ryo Kurosawa¹, Takeshi Noda^{2, 3}, Masatoshi Hagiwara¹ (1.Grad. Sch. of Med., Kyoto University, 2.Institute for Frontier Life and Medical Sciences, Kyoto University, 3.CREST, Japan Science and Technology Agency)

f . RNA / Ribonucleoprotein(1 . Molecular)